Anlon Healthcare (NSE:AHCL) Other Financing: ₹0 Mil (TTM As of Mar. 2026)


NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
28 GF Score
Price ₹15.87
! 5 Warning Signs
View Full Analysis

What is Anlon Healthcare Other Financing?

Anlon Healthcare NSE:AHCL -0.19% 28 Other Financing is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 28/100. The stock has 5 warning signs investors should review.

Anlon Healthcare's Other Financing for the three months ended in Mar. 2026 was ₹0 Mil.

Anlon Healthcare's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Anlon Healthcare Other Financing Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare Other Financing Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing
-40.72 -37.98 -39.31 -37.15 202.51

Anlon Healthcare Quarterly Data
Mar22 Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:AHCL
28GF Score
Anlon Healthcare Ltd NSE:AHCL
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹0 Mil mean?
Anlon Healthcare (NSE:AHCL) has a Other Financing of ₹0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Anlon Healthcare and its competitors.
Is Anlon Healthcare's Other Financing too high?
Anlon Healthcare's current Other Financing is ₹0 Mil. Overall, Anlon Healthcare has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Other Financing compare to ZTS and UTHR?
Anlon Healthcare's Other Financing of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Anlon Healthcare and its competitors. Anlon Healthcare's current Other Financing is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Other Financing of ₹0 Mil. The current Other Financing is ₹0 Mil. Anlon Healthcare's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Other Financing is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
28GF Score

Get the complete analysis for NSE:AHCL

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.87
Price